UFP Technologies, Inc. Accounts Receivable, Allowance for Credit Loss, Recovery
UFP Technologies, Inc. (UFPT) reported Accounts Receivable, Allowance for Credit Loss, Recovery of $2.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › and Others › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries · last filed 2026-02-27
- UFP Technologies, Inc. accounts receivable, allowance for credit loss, recovery for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- UFP Technologies, Inc. accounts receivable, allowance for credit loss, recovery for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- UFP Technologies, Inc. accounts receivable, allowance for credit loss, recovery for the quarter ending 2023-12-31 was $1.00K, a 93.33% decline year-over-year.
- UFP Technologies, Inc. accounts receivable, allowance for credit loss, recovery for the quarter ending 2023-09-30 was $1.00K.
- UFP Technologies, Inc. accounts receivable, allowance for credit loss, recovery for fiscal 2025 was $2.00K.
- UFP Technologies, Inc. accounts receivable, allowance for credit loss, recovery for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- UFP Technologies, Inc. accounts receivable, allowance for credit loss, recovery for fiscal 2023 was $10.00K, a 33.33% decline from fiscal 2022.
- UFP Technologies, Inc. accounts receivable, allowance for credit loss, recovery for fiscal 2022 was $15.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Recovery 3 month | Accounts Receivable, Allowance for Credit Loss, Recovery 6 month | Accounts Receivable, Allowance for Credit Loss, Recovery 9 month | Accounts Receivable, Allowance for Credit Loss, Recovery 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.00K 10-K · filed 2026-02-27 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-09 | |||
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $2.00K derived: sum of 2 quarters · filed 2025-03-03 | $10.00K 10-K · filed 2025-03-03 | |
| 2023-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $9.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $8.00K 10-Q · filed 2024-08-09 | |||
| 2022-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $15.00K derived: sum of 2 quarters · filed 2024-02-29 | $15.00K 10-K · filed 2024-02-29 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |